The COVID-19 pandemic has put unusual pressures on the supply and demand of raw materials required for the production and purification of biologics. A specific concern for the biomanufacturing industry is the availability of materials that make up essential buffer components.

Buffers maintain defined conditions that help stabilize proteins through production, purification, formulation, and storage so their composition is important.

In March of 2021, Angela Linderholm, Jennifer Bratt, and Steven Chamow of Chamow & Associates, an Alira Health company, with S. Anne Montgomery co-authored a Q&A style article on topics related to buffer supply.

Read the full article published in BioProcess International here: https://lnkd.in/eeNDuxv